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Tomosyn is a 130-kDa syntaxin-binding protein that
contains a large N-terminal domain with WD40 repeats
and a C-terminal domain homologous to R-SNAREs.
Here we show that tomosyn forms genuine SNARE core
complexes with the SNAREs syntaxin 1 and SNAP-25. In
vitro studies with recombinant proteins revealed that
complex formation proceeds from unstructured mono-
mers to a stable four-helical bundle. The assembled
complex displayed features typical for SNARE core com-
plexes, including a profound hysteresis upon unfolding-
refolding transitions. No stable complexes were formed
between the SNARE motif of tomosyn and either syn-
taxin or SNAP-25 alone. Furthermore, both native tomo-
syn and its isolated C-terminal domain competed with
synaptobrevin for binding to endogenous syntaxin and
SNAP-25 on inside-out sheets of plasma membranes. To-
mosyn-SNARE complexes were effectively disassembled
by the ATPase N-ethylmaleimide-sensitive factor to-
gether with its cofactor -SNAP. Moreover, the C-termi-
nal domain of tomosyn was as effective as the cytoplas-
mic portion of synaptobrevin in inhibiting evoked
exocytosis in a cell-free preparation derived from PC12
cells. Similarly, overexpression of tomosyn in PC12 cells
resulted in a massive reduction of exocytosis, but the
release parameters of individual exocytotic events re-
mained unchanged. We conclude that tomosyn is a sol-
uble SNARE that directly competes with synaptobrevin
in the formation of SNARE complexes and thus may
function in down-regulating exocytosis.
Neurotransmitter release is mediated by regulated exocyto-
sis of synaptic vesicles. Exocytosis is carried out by membrane
fusion machines involving evolutionary conserved proteins that
are common to all fusion events of the secretory pathway in
eukaryotic cells. Among the conserved proteins are the
SNAREs,1 small membrane proteins characterized by homolo-
gous stretches of 60–70 amino acids referred to as SNARE
motifs (1). The SNAREs involved in neuronal exocytosis in-
clude the vesicle protein synaptobrevin (also termed VAMP),
and the plasma membrane-associated proteins syntaxin 1 and
SNAP-25 (acronym for synaptosome-associated protein of 25
kDa). These proteins undergo an assembly-disassembly cycle
that involves the SNARE motifs and that is associated with
large structural and energetic changes (2, 3). It is currently
believed that assembly leads to a tight connection between the
vesicle and the plasma membrane that initiates the opening of
the fusion pore (for review see Refs. 4 and 5).
The components of the basic fusion apparatus are acted upon
by arrays of control proteins that are responsible for the spe-
cific features of each fusion reaction. For the SNARE proteins
involved in neuronal exocytosis many candidate regulator pro-
teins have been identified, but their molecular mechanisms are
only beginning to be understood (5). Considering the central
role of SNARE assembly and disassembly for exocytosis, it is
thus necessary to understand in detail which of such regulatory
proteins interact with the SNARE conformational cycle and
how exactly the cycle is influenced.
Tomosyn is a candidate regulatory protein that was first
identified as a binding protein for syntaxin 1 (6). Tomosyn is a
130-kDa protein that lacks a membrane anchor and in which
two domains are distinguished: a small C-terminal region with
homology to the R-SNARE subfamily of SNAREs and a large
N-terminal region that contains WD40 repeats and shares sim-
ilarities with the Drosophila tumor suppressor lethal (2) giant
larvae (l(2)gl) (7), its recently characterized mammalian homo-
logue MglI (8), and the yeast proteins Sro7p and Sro77p (9).
Three splicing variants of tomosyn are known, two of which are
predominantly expressed in brain, whereas one is ubiquitously
distributed (10).
Tomosyn has been reported to bind to the SNARE motif of
syntaxin (11). In tissue extracts, tomosyn was found to be
associated with syntaxin, SNAP-25, and synaptotagmin but
not with synaptobrevin (6). Binding of synaptobrevin and to-
mosyn appear to be mutually exclusive leading to the sugges-
tion that tomosyn may regulate synaptobrevin binding to the
other SNAREs. Furthermore, it was suggested that tomosyn
displaces Munc18 from syntaxin (6). Munc18 is a conserved
protein essential for exocytosis that forms tight complexes with
syntaxin 1 in vitro. Munc18 binding maintains syntaxin in an
inactive state and inhibits formation of SNARE complexes (12,
13). Hence, it has been proposed that tomosyn may activate
syntaxin, allowing it to interact with synaptobrevin in prepa-
ration for exocytosis (6). On the other hand, overexpression of
tomosyn in PC12 cells resulted in a slight but significant inhi-
bition of exocytosis (6, 13) suggesting that the role of tomosyn
cannot be confined to an activator of membrane fusion.
Interestingly, the binding region of tomosyn could be as-
signed to the C-terminal region containing the R-SNARE motif
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raising the possibility that tomosyn may substitute as an R-
SNARE in the formation of SNARE complexes (10, 11). SNARE
complexes are represented by bundles of four -helices in which
each helix is contributed by a single SNARE motif (14, 15). All
helices are aligned in parallel, with the transmembrane do-
mains extending at one end. The -helices are connected by
layers of interacting amino acid side chains that are mostly
hydrophobic and thus characteristic for coiled-coils. In the cen-
ter, an unusual polar layer was observed consisting of three
glutamines contributed by syntaxin and the two SNARE motifs
of SNAP-25, and one arginine contributed by synaptobrevin
(14). These residues are among the most highly conserved of
the SNARE protein superfamily and led to the classification of
SNAREs into Q- and R-SNAREs, respectively (16). If tomosyn
substitutes as an R-SNARE for synaptobrevin in core com-
plexes, it would be expected to interfere with synaptobrevin
binding before fusion, thus acting as an inhibitor rather than
an activator of SNARE function. However, it is still unknown
whether tomosyn forms SNARE core complexes, whether it can
interact with membrane-bound SNAREs, or whether it inter-
feres with the SNARE association-dissociation cycle.
In the present study, we show that the C-terminal domain of
tomosyn functions as a genuine R-SNARE motif. Tomosyn
SNARE complexes exhibit features typical for SNARE core
complexes, and they are sensitive to disassembly by the
ATPase NSF. The R-SNARE motif of tomosyn directly com-
petes with synaptobrevin during complex formation with the
plasma membrane-resident Q-SNAREs syntaxin 1 and SNAP-
25. Membrane binding is exclusively mediated by the SNARE
motif of tomosyn that is also responsible for the inhibitory
action of the protein on exocytosis. Neither binding nor NSF-
mediated dissociation appears to be affected by the large N-
terminal domain of tomosyn, leaving the function of this do-
main still unexplained.
EXPERIMENTAL PROCEDURES
Materials—The expression constructs of synaptobrevin 2 (1–96)
S28C and of a chimera of human neuropeptide Y with EGFP (NPY-
EGFP) were described previously (17, 18). NSF and -SNAP were
expressed and purified as described previously (19). Mouse monoclonal
antibodies were used for the following proteins: syntaxin 1A/B (Cl 78.3),
GDI (Cl 81.2), NSF (Cl 83.13, raised against recombinant NSF),
SNAP-25 (Cl 71.1), synaptobrevin (Cl 69.1), -SNAP (Cl 77.2), and
c-Myc (9E10, purchased from ATCC). With the exception of Cl 83.13,
which has not yet been published, all other antibodies were obtainable
from Synaptic Systems (Go¨ttingen, Germany). A rabbit polyclonal an-
tibody raised against syntaxin 1A (R31) was used for the detection of
syntaxin 1A (18). An antibody to tomosyn was raised in rabbits against
a C-terminal fragment (tomosyn: residues 985–1051) that was ex-
pressed as a GST fusion protein in Escherichia coli using pGEX-KG
(Amersham Biosciences). This antibody was purified on affinity chro-
matography of Sepharose 4B (Amersham Biosciences) coupled with
GST-tomosyn-(985–1051).
Molecular Cloning—The cDNA corresponding to the open reading
frame of rat m-tomosyn-(1–1116) was amplified by PCR using the Pfu
Turbo DNA polymerase (Stratagene) from rat cerebellum cDNA librar-
ies (Stratagene). The fragment was subcloned into pBluescript vector
(Stratagene) and then sequenced to confirm the identity with the pub-
lished sequence.
The sequences encoding for tomosyn-(1–1116), tomosyn-(1–1030),
tomosyn (1031–1116) were amplified by PCR from pBlue-tomosyn-(1–
1116). Unless indicated otherwise, the 5-primers were designed to add
an myc epitope upstream of the respective 5-ends. The fragments were
subcloned into the mammalian expression plasmids pCR3.1 (Invitro-
gen) or pBOB1.5 (pBOB1.5-EGFP was a gift from T. Hughes, Yale
University, New Haven, CT) to express proteins fused with the N-
terminal myc epitope for tomosyns, named, respectively, myc-tomosyn,
myc-N-tom, and myc-C-tom. The sequences encoding tomosyn-(985–
1051) and tomosyn-(1051–1116) were subcloned into the bacterial ex-
pression vector pGEX-KG to produce fusion proteins containing an
N-terminal GST moiety.
Purification of Recombinant Proteins—The tomosyn fragment (resi-
dues 985–1051) and the tomosyn-SNARE-motif (residues 1051–1116)
were expressed in E. coli as N-terminal GST-tagged proteins and puri-
fied by glutathione-Sepharose (Amersham Biosciences). The GST-
tagged tomosyn-SNARE-motif-(1051–1116) was digested by thrombin
to remove the tag and was further purified on a Mono-S column using
an A¨kta FPLC-system (Amersham Biosciences).
His6-tagged versions of the SNARE-motif (H3-domain) of syntaxin
1A-(180–262), SNAP-25 (1–206, all native cysteines replaced by
serines), and the N- (1–83) and C-terminal (120–206) SNARE-motifs of
SNAP-25 were purified by Ni2-agarose. After removal of the tag by
thrombin, all proteins were further purified using a Mono-Q column on
an A¨kta system (Amersham Biosciences) essentially as described (20,
21). All proteins were 95% pure as determined by SDS-PAGE and
Coomassie Blue staining.
For assembly of the tomosyn-containing SNARE core complex,
equimolar amounts of the tomosyn-SNARE-motif-(1051–1116), syn-
taxin 1A-(180–262), and SNAP-25 were incubated overnight at 4 °C.
The complex was purified by ion exchange and size exclusion chroma-
tography (Mono-Q column) and HiLoad1660 Superdex 200 column (Am-
ersham Biosciences).
Cell Culture, Fractionation, and Immunoprecipitation—For subcel-
lular fractionation, PC12 cells, grown at 70% confluence on two
150-mm dishes, were washed twice with ice-cold phosphate-buffered
saline (PBS containing 150 mM NaCl, 2.5 mM KCl, 10 mM Na2HPO4, 2
mM KH2PO4, pH7.4). They were then homogenized by passage fifteen
times through a 23-gauge needle in 2 ml of ice-cold homogenization
buffer A (20 mM HEPES-KOH, pH 7.2, 0.25 M sucrose) containing a
complete protease inhibitor mixture (Roche Diagnostics) and centri-
fuged at 2,500 rpm for 10 min at 4 °C in a microcentrifuge to remove
nuclei and unbroken cells. The postnuclear supernatant was then cen-
trifuged at 120,000  g for 60 min at 4 °C to obtain a membrane pellet.
For immunoprecipitations, this pellet was solubilized in 1% Triton
X-100, 20 mM HEPES-KOH, pH 7.2, 2 mM EDTA, 100 mM KCl, 1 mM
DTT containing the complete inhibitor mixture, incubated for 10 min at
4 °C, and then cleared by centrifugation at 13,000 rpm for 20 min at
4 °C in a microcentrifuge. Aliquots containing each 200 g of protein
were incubated for 30 min at 4 °C with affinity-purified antibodies
against tomosyn (25 g of protein), monoclonal antibodies against syn-
taxin 1 A/B (Cl 78.3), or monoclonal antibodies against the myc-epitope
(100 g of purified IgG in each case). Protein A-Sepharose or Protein
G-Sepharose (Amersham Biosciences) was then added and allowed to
incubate for 12 h at 4 °C with gentle rotation. The beads were sedi-
mented in a microcentrifuge and washed four times in lysis buffer. All
precipitates were treated with SDS-sample buffer and analyzed by
SDS-PAGE and immunoblotting.
For measuring NSF-driven release of tomosyn, postnuclear superna-
tant of PC12 cells was treated with 4 mM N-ethylmaleimide for 30 min
on ice to inactivate endogenous NSF and then quenched by adding 8 mM
DTT before isolation of a membrane pellet. The pellets were resus-
pended in 20 mM HEPES-KOH, pH 7.2, 100 mM KCl, 1% (v/v) glycerol,
100 M phenylmethylsulfonyl fluoride supplemented (where indicated)
with 2 mM ATP, 4 mM MgCl2, an ATP-regenerating system (20 mM
creatine phosphate and 0.1 mg/ml creatine kinase), 0.6 M NSF, and 6
M -SNAP with or without 10 mM EDTA, incubated for 30 min at
37 °C, and centrifuged again as above.
Competition Assay—The single cysteine at position 28 of synaptobre-
vin 2-(1–96)-S28C was labeled with a 10-fold molar excess of Alexa594
C5 maleimide (Molecular Probes Inc., Eugene, OR) according to the
manufacture’s instruction. The labeled protein was separated by gel
filtration from the dye.
Rat brain cytosol (1 mg) was incubated for 30 min at 4 °C with
anti-tomosyn antibody or control IgG (100 g each) in KGlu buffer (20
mM HEPES, pH 7.2, 120 mM potassium glutamate, 20 mM potassium
acetate, 2 mM EGTA) and added to 30 l of Protein A-Sepharose (50%
slurry) to deplete endogenous tomosyn in the cytosol. After incubation
for 1 h at 4 °C with gentle rotation, supernatant fraction was collected
by centrifugation (immunodepleted cytosol fraction).
PC12 cells were grown on poly-L-lysine-coated coverslips and dis-
rupted as previously described (23) using a 100-ms ultrasound treat-
ment in ice-cold sonication buffer (KGlu buffer containing 10 mM EGTA,
2 mM ATP, 4 mM MgCl2, and 0.5 mM DTT). The membrane sheets were
then incubated in KGlu buffer containing 2 mM ATP, 5 mM MgCl2, 1 mM
DTT, 30 mg/ml bovine serum albumin, and 5 M Alexa 594-labeled
synaptobrevin 2-(1–96)-S28C together with competitors (synaptobrevin
2-(1–96)-S28C, tomosyn-(1051–1116), lysozyme, or rat brain cytosol (1
mg/ml each)) for 30 min at 37 °C. Membranes were washed twice in
KGlu buffer quickly and fixed for 30 min at room temperature in 4%
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paraformaldehyde in PBS. They were then washed twice in PBS for 20
min each. Imaging of the membrane sheets and quantification of fluo-
rescence was performed as previously described (24).
In Vitro Exocytosis Assay—For the in vitro exocytosis assay, PC12
cells expressing the secretory granule marker neuropeptide Y-EGFP
(18, 22) were used. At 40–50 h after transfection, membrane sheets
were generated as described above and preincubated for 10 min at room
temperature in KGlu buffer with 80 M of the inhibitors as indicated
(synaptobrevin 2-(1–96)-S28C, tomosyn-(1051–1116), or lysozyme). Af-
ter preincubation, membrane sheets with at least 15 brightly fluores-
cent granules were stimulated using KGlu buffer containing 0.5 mg/ml
rat brain cytosol, 0.5 M [Ca2]free buffered with 10 mM EGTA (see Ref.
25) and 80 M of the corresponding inhibitors. For controls, membrane
sheets were incubated with KGlu buffer containing rat brain cytosol
and 2 mM EGTA. The membrane sheets were imaged every min for 30
min. The focal position of the objective was controlled throughout all
experiments using a low voltage piezo translator drive and a linear
variable transformer displacement sensor/controller (Physik Instru-
mente, Waldbronn, Germany). Finally, the membrane sheets were vi-
sualized using TMA-DPH (Molecular Probes). Imaging and image anal-
ysis were performed as previously described (25).
Carbon Fiber Amperometry—Carbon fiber amperometry was used
essentially as described previously (26). Amperometric signals from
PC12 cells were recorded with an EPC-7 amplifier (Heka Electronics)
with a holding potential of the carbon fiber set to 800 mV. The tip of
the fiber was brought into direct contact with the plasma membrane to
minimize temporal distortion of the release signal and diffusional loss
of the released transmitter amount. Experiments were performed in
Ringer’s solution containing 130 mM NaCl, 4 mM KCl, 10 mM Hepes, pH
7.4, 1 mM MgCl2, 5 mM CaCl2, 44 mM glucose. Using a multichannel
perfusion pipette (27) a depolarizing stimulus was applied by rapid
superfusion with 80 mM NaCl, 50 mM KCl, 1 mM MgCl2, 5 mM CaCl2, 44
mM glucose, 10 mM Hepes, pH 7.4. Stimulation periods were bracketed
by superfusion with Ringer’s solution. Signals were filtered with 3 and
10 kHz, digitized at 25 kHz, and stored on a personal computer. For
data analysis, the AutesW software (NPI Electronics, Tamm, Germany)
was used as described in a previous study (26). Signals were again
digitally filtered at 3 kHz (overall bandwidth, 2.1 kHz). Additionally, a
routine for analysis of foot events preceding the main amperometric
spike was included (see Table I for details).
PC12 cells (28) (passage numbers 27–33) were cultured as described
previously (29). For transfection, cells were electroporated (Gene
Pulser, Bio-Rad, settings: resistance 50 ohm, capacitor 50 microfarads,
voltage 1.1 kV, cuvette 4-mm gap) in a solution containing 85 mM KCl,
10 mM NaCl, 10 mM KH2PO4, 10 mM K2HPO4, 5 mM MgCl2, 2 mM EGTA,
0.15 mM CaCl2, 50 mM glucose, 25 mM Hepes-KOH, pH 7.6. Control cells
were sham-transfected with pCDNA3 (containing no insert, Invitro-
gen), whereas tomosyn-overexpressing cells were transfected with
pBOB1.5-tomosyn encoding for the entire open reading frame of
m-tomosyn-(1–1116) with a myc-tag fused to the N-terminal end of the
protein. Overexpressing cells were identified by co-transfection with
pBOB1.5-EGFP coding for EGFP as marker protein. A molar ratio of 5
to 1 for pBOB1.5-tomosyn versus pBOB1.5-EGFP was used to guaran-
tee a high co-transfection efficiency (85%) as judged from immunosig-
nals of transfected cells processed in parallel. For amperometric record-
ings, only cells that exhibited strong EGFP signals were used. Cells
were plated on collagen-coated culture dishes (Falcon 3001) at densities
between 1  106 and 1.5  106 cells/dish and were used for recordings
3–4 days after transfection.
Other Methods—SDS-PAGE and immunoblotting was carried out
using standard procedures. Electroblotting was performed on Immo-
bilon-P membranes (Millipore, Bedford, MA). As secondary antibodies,
we used horseradish peroxidase-conjugated anti-rat IgG or anti-mouse
IgG, and the blots were developed by enhanced chemiluminescence
using SuperSignal West (Pierce) according to the manufacture’s in-
structions. Multiangle laser light scattering measurements and CD
spectroscopy were performed as described (3, 21).
RESULTS
The C-terminal Domain of Tomosyn Forms SNARE Core
Complexes—SNARE core complexes display several highly un-
usual properties, including progression from unstructured
monomers to helical bundles upon assembly, extraordinary
heat stability, and profound hystereses upon unfolding-refold-
ing cycles (3). To examine whether the C-terminal domain of
tomosyn can function as a genuine R-SNARE in the formation
of core complexes, purified recombinant SNARE motifs of to-
mosyn, syntaxin 1, and SNAP-25 were combined, and the fea-
tures of the resulting complexes were studied.
First, we used circular dichroism (CD) spectroscopy to exam-
ine whether binding of tomosyn to syntaxin 1 and SNAP-25
involves a transition from unstructured monomers into a heli-
cal bundle. As shown in Fig. 1A, a large increase in -helical
content was observable when the SNARE motif of tomosyn was
mixed with SNAP-25 and syntaxin. No secondary structure
was detectable in the CD spectrum of the isolated SNARE
motifs (Fig. 1A). Furthermore, no structural change was ob-
served when the SNARE motif of tomosyn was combined with
SNAP-25 or with its isolated SNARE motifs, and only a minor
increase was observed upon mixing with the H3 domain of
syntaxin 1 (Fig. 1B). For further characterization, tomosyn-
containing SNARE complexes were purified by ion exchange
chromatography. When analyzed by size-exclusion chromatog-
raphy and multiangle laser light scattering, the purified com-
plex migrated largely as a single peak with a molecular mass of
45,000 Da (data not shown), as expected for a complex with a
1:1:1:1 stoichiometry.
We then tested whether the tomosyn-SNARE complex is
heat-stable, and if so, whether heat denaturation and re-natur-
ation would display hysteresis characteristic for SNARE core
complexes (3). Fig. 1C shows that the tomosyn SNARE complex
has an unfolding transition temperature of over 80 °C whereas
re-folding requires temperatures below 60 °C. Together, these
properties are indistinguishable from SNARE complexes con-
taining synaptobrevin (3) documenting that the R-SNARE mo-
tif of tomosyn is fully functional in substituting for synaptobre-
vin as R-SNARE.
The N-terminal Domain of Tomosyn Does Not Interfere with
the Activity of the R-SNARE Motif—Tomosyn possesses a large
N-terminal domain of unknown function that could block or
down-regulate the activity of the SNARE motif, at least in
intact preparations. We therefore investigated whether tomo-
syn is complexed with syntaxin and SNAP-25 in intact cells,
and if so, if the presence of the N-terminal domain has any
influence on this interaction.
Tomosyn was immunoprecipitated from detergent extracts of
PC12 cells and tested for association of SNARE proteins (Fig.
2A). Both syntaxin 1 and SNAP-25 co-precipitated with tomo-
syn, showing that native tomosyn interacts with these SNAREs
in intact cells. Furthermore, a minor amount of synaptobrevin
was found in the immunoprecipitate, which may be due to
interactions involving the transmembrane domains rather
than the SNARE motifs (30). Conversely, tomosyn co-precipi-
tated with syntaxin when a monoclonal antibody specific for
the N-terminal domain of syntaxin was used (Fig. 2B).
To estimate the contribution of the N-terminal domain of
tomosyn to the formation of SNARE complexes, we transfected
PC12 cells with expression vectors coding for myc-tagged ver-
sions of full-length tomosyn, the N-terminal domain (residues
1–1030), and the C -terminal region carrying the R-SNARE
motif (residues 1031–1116). Immunoprecipitations were then
performed from detergent extracts of PC12 cells as above using
an anti-myc antibody. As shown in Fig. 2C, both syntaxin 1 and
SNAP-25 co-precipitated with the tomosyn variants containing
the R-SNARE motif. In contrast, these SNAREs were not de-
tectable in immunoprecipitates obtained from cells transfected
with the N-terminal domain of tomosyn. In this case, synapto-
brevin was not detectable in any of the immunoprecipitates.
Next we investigated whether the R-SNARE motif of tomo-
syn substitutes for synaptobrevin when SNARE complexes are
formed in intact membranes. To address this issue, we took advan-
tage of our recent finding that the recombinant R-SNARE motif of
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synaptobrevin forms core complexes with endogenous membrane-
resident SNAP-25 and syntaxin 1 when added to freshly prepared
inverted sheets of plasma membranes (24). PC12 cells were grown
on coverslips and subjected to brief sonication to disrupt the cells,
resulting in the generation of inside-out membrane sheets. The
membrane sheets were incubated for 30 min at 37 °C with recom-
binant synaptobrevin (lacking the transmembrane domain) that
was labeled with the fluorescent dye Alexa 594. As shown in Fig. 3,
synaptobrevin bound to syntaxin clusters in these membrane
sheets resulting, as shown previously (24), in the formation of
genuine cis-core complexes. As expected for a specific and saturable
interaction, binding of labeled synaptobrevin was progressively
reduced when increasing amounts of unlabeled protein were added
(Fig. 3G). When synaptobrevin was replaced with the SNARE motif
of tomosyn in these experiments, competition with the binding of
labeled synaptobrevin was of comparable efficacy. These data show
FIG. 1. The SNARE motif of tomosyn forms SNARE core com-
plexes with syntaxin 1 and SNAP-25. A, CD spectra of purified
SNAP-25, of the H3-domain of syntaxin 1 (residues 180–262), of the
C-terminal region of tomosyn (residues 1051–1161), and of a mixture of
all three proteins. The spectra of the monomers show no evidence for
secondary structure. Note the decrease in ellipticity of the mixture, with
minima at 208 and 222 nm, which are typical for -helices. B, signifi-
cant increases in -helicity are only observed when tomosyn is com-
bined with both SNARE motifs of SNAP-25 and that of syntaxin. The
figure shows a comparison of the ellipticities (220 nm) of the theoreti-
cally non-interacting spectra (black bars) and the measured spectra
(open bars). H3, H3 domain of syntaxin; SN1, N-terminal SNARE motif
of SNAP-25 (residues 1–83); SN2, C-terminal SNARE motif of SNAP-25
(residues 120–206). C, tomosyn-SNARE complexes show profound hys-
teresis upon thermal unfolding-refolding cycles. Folding was deter-
mined by monitoring helical content with CD spectroscopy at 220 nm.
Complexes were formed with tomosyn-(1051–1161), syntaxin-(180–
262), and full-length SNAP-25, purified by anion exchange and size-
exclusion chromatography and subjected to heating and cooling at the
rates indicated (see Ref. 3, for further details).
FIG. 2. Tomosyn forms SNARE complexes with syntaxin and
SNAP-25 in PC12 cells. A and B, co-immunoprecipitation of tomosyn,
syntaxin, and SNAP-25 from detergent extracts of PC12 cell mem-
branes using either affinity-purified anti-tomosyn antibodies (A) or an
anti-syntaxin monoclonal antibody (B). C, co-immunoprecipitation of
myc-tagged tomosyn variants expressed in PC12 cells with SNARE
proteins. PC12 cells were transfected with expression plasmids carry-
ing N-terminally fused myc-tags that encode full-length tomosyn (myc-
tomosyn), the N-terminal domain of tomosyn (residues 1–1030, myc-N-
tom), and the C-terminal domain of tomosyn containing the R-SNARE
motif (residues 1031–1116, myc-C-tom). Two days after transfection,
immunoprecipitations were performed from membrane extracts using
anti-myc antibodies. All immunoprecipitates were analyzed by SDS-
PAGE and immunoblotting.
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that the proteins bind to the same site with similar affinities.
We next investigated whether full-length tomosyn is also
capable of competing with synaptobrevin binding in this assay.
Unfortunately, we have so far been unable to prepare recom-
binant full-length tomosyn for binding studies. We therefore
took an indirect approach and used whole brain cytosol as a
source for endogenous tomosyn. To account for effects by fac-
tors other than tomosyn, part of the cytosol was depleted of
endogenous tomosyn by immunoprecipitation resulting in
near-quantitative removal of the endogenous protein (Fig. 3I)
with no detectable changes in the overall protein pattern (not
shown). Addition of cytosol to the binding reaction that was
pretreated with a control IgG resulted in efficient competition
of synaptobrevin binding (Fig. 3H). Equal concentrations of
immunodepleted cytosol were significantly less efficient, al-
though some inhibitory activity remained. Addition of the re-
combinant SNARE motif of tomosyn to the reaction was as
effective in competing with synaptobrevin as in the absence of
cytosol. Thus, native tomosyn forms SNARE complexes with
syntaxin and SNAP-25, and there appears to be no interference
by cytosolic factors with the R-SNARE activity of the protein.
The data described so far suggests that the large N-terminal
domain does not interfere with the ability of the C-terminal
SNARE motif to enter SNARE complexes. However, it remains
to be established whether the same applies to the “reverse”
reaction, i.e. whether SNARE complexes containing native to-
mosyn can be disassembled by the ATPase NSF.
Membrane fractions, prepared from PC12 cells, were pre-
treated with N-ethylmaleimide to block endogenous NSF and
then incubated with ATP either in the absence or the presence
of recombinant NSF and -SNAP. NSF treatment resulted in a
release of tomosyn from the membrane that was dependent on
the presence of Mg-ATP (Fig. 4). Similarly, tomosyn could be
removed from the plasma membrane of digitonin-permeabi-
lized PC12 cells upon incubation with ATP-NSF (data not
shown). We conclude that neuronal SNARE complexes contain-
ing tomosyn are effectively disassembled by NSF.
The SNARE Motif of Tomosyn Is Responsible for Down-
regulating Exocytosis in PC12 Cells—So far we have estab-
lished that the R-SNARE motif of tomosyn forms SNARE com-
plexes with syntaxin and SNAP-25 that can be disassembled by
NSF and that are similar to core complexes containing synap-
tobrevin. It has previously been shown that overexpression of
tomosyn causes partial inhibition of exocytosis in PC12 cells
(6), and it has been proposed that the tomosyn may mediate its
inhibition by functionally substituting an R-SNARE motif.
To investigate whether the R-SNARE motif of tomosyn is
indeed responsible for inhibiting exocytosis in PC12 cells, we
took advantage of a recently developed cell-free system for
exocytosis that is based on the preparation of membrane sheets
similar to those described above. We have shown previously
that such membrane sheets contain bound secretory granules
that retain their ability to undergo Ca2-dependent exocytosis
for some time after cell disruption (23). PC12 cells whose se-
cretory granules were fluorescently labeled by expression of
neuropeptide Y-EGFP (18) were grown on coverslips and son-
icated to produce plasma membrane sheets containing labeled
secretory granules (Fig. 5). Exocytosis was monitored by
changes in the fluorescence intensity as described (23, 25). After
a preincubation period of 10 min in the presence of cytosol and
ATP, calcium was added, resulting in a calcium-dependent exo-
cytic activity of 21% of all granules during the subsequent 30
FIG. 3. Tomosyn competes with Alexa594-labeled synaptobre-
vin 2 (1–96, S28C) in binding to inverted lawns of plasma mem-
branes derived from PC12 cells. A–F, Alexa594-labeled synaptobre-
vin 2-(1–96) binds to endogenous syntaxin 1 clusters that were
immunolabeled after the binding reaction. A, immunostaining for syn-
taxin 1A. B, bound Alexa-labeled synaptobrevin. C, the position and the
integrity of the membrane sheets were documented with TMA-DPH, a
lipophilic membrane dye. D and E, magnified views from A and B; see
F for overlay. G, competition of binding of Alexa594-labeled synapto-
brevin with unlabeled recombinant proteins. All sheets were washed
and fixed after the binding reaction, and the fluorescence intensity of
the membrane sheets was measured (see “Experimental Procedures”).
Values are presented as means  S.E. (n  30 membrane sheets). H,
competition of synaptobrevin binding using tomosyn-containing cytosol
that was either immunodepleted with control IgG or with anti-tomosyn
antibodies. Treatment with anti-tomosyn antibodies led to near quan-
titative removal of tomosyn (immunoblot analysis shown in I). As con-
trol, all cytosol fractions were heat-inactivated prior to the experiment.
FIG. 4. Tomosyn is released from membranes by NSF and
-SNAP. Immunoblots of PC12 cell membranes and the corresponding
supernatants that were incubated with NSF and -SNAP. Incubation
was carried out for 30 min at 37 °C with either an ATP-regenerating
system (ATP) or an ATP-regenerating system supplemented with
EDTA to inactivate ATP-cleavage due to chelation of Mg2. Where
indicated, purified recombinant NSF and -SNAP (each at 6 M final
concentration) were added. The membrane fractions were pretreated
with 4 mM N-ethylmaleimide on ice for 30 min prior to membrane
isolation to inactivate endogenous NSF (see “Experimental Proce-
dures”). After the incubation, membranes were sedimented by high
speed centrifugation, and equal proportions of the pellet (P) and super-
natant (S) fractions were analyzed by SDS-PAGE and immunoblotting.
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min (Fig. 5D). When recombinant synaptobrevin-(1–96) was
added, exocytosis was largely inhibited. A very similar inhibition
was observed when the C-terminal part of tomosyn was added.
In the final set of experiments, we addressed whether tomo-
syn overexpression has an impact on the exocytotic fusion
event itself. It has previously been reported that tomosyn over-
expression in PC12 cells leads to a slight reduction in the
release of co-transfected human growth hormone (6). To gain
more insight into the underlying mechanism, we analyzed the
effect of tomosyn overexpression on the frequency and release
parameters of dopamine release from single secretory vesicles.
PC12 cells were co-transfected with full-length tomosyn and
EGFP to identify transfected cells, and exocytosis was moni-
tored by carbon fiber amperometry. Upon depolarizing stimu-
lation with high K-containing solution control cells respond
with an initial phase of high exocytotic activity (2.1  0.8
events/s), which slowly declined to proceed at a more constant
rate (1.1  0.4 events/s) as long as the stimulus was applied
(Fig. 6). Tomosyn-expressing cells showed no biphasic response
but exocytosed vesicles with an average rate of about 0.25 0.1
events/s. The lack of an initial phase with higher exocytotic
activity suggests that the number of rapidly releasing granules
is strongly diminished upon overexpression of tomosyn. In con-
trast, no significant changes were observed in the analysis of
the single spike parameters, including the quantal size, ampli-
tude, rise time, and half-width of the event and in the param-
eters of the amperometric foot signal that represents the open-
ing kinetics of the exocytotic fusion pore (Table I). Taken
together, the data suggest that tomosyn governs the readiness
of the secretory organelles for exocytosis rather than the mo-
lecular mechanism of membrane merger.
DISCUSSION
In the present study we have shown that the C-terminal
portion of tomosyn acts as a fully functional R-SNARE motif
with similar properties to the R-SNARE motif of synaptobre-
vin. It mediates membrane binding by forming SNARE com-
plexes with syntaxin 1 and SNAP-25 that are sensitive to
disassembly by NSF. Furthermore, it mimics the inhibitory
action of the SNARE motif of synaptobrevin on exocytosis (31,
32). In contrast to synaptobrevin, tomosyn does not contain a
membrane anchor domain but has a large N-terminal domain
that does not appear to interfere with the SNARE activity of
the C terminus.
As outlined in the introduction, tomosyn is related to the
Drosophila tumor suppressor lethal (2) giant larvae (l(2)gl) (7),
its mammalian homologue MglI (8) and the yeast proteins
Sro7p and Sro77p (9). The homology is confined to the N-
terminal domain containing WD40 repeats, protein binding
domains with a conserved structure of about 40 residues, each
containing a central Trp-Asp motif. WD40 domains are in-
volved in specific protein-protein interactions, best character-
ized in G protein-mediated signal transduction (33). In contrast
to tomosyn, none of the hitherto known relatives possess a
SNARE motif (based on unpublished sequence comparisons,
see also “Discussion” in Ref. 8). Intriguingly, however, several
of the other family members have not only been demonstrated
to play a role in membrane traffic of polarized cells but also to
directly interact with intracellular SNAREs. In yeast, cells
deficient in SRO7 and SRO77 exhibit a defect in vesicle trans-
port from the Golgi apparatus to the plasma membrane, and
the protein Sro7p binds to the yeast SNAP-25 homologue Sec9p
(9). Furthermore, MglI appears to play a role in polarized
membrane trafficking as it becomes associated with the lateral
membrane when MDCK cells establish polarity, and mem-
brane binding of MglI seems to be mediated by binding to
syntaxin 4 (8). These findings contrast with our observation
that the N-terminal domain of tomosyn does not interact with
membranes. Furthermore, Yokoyama et al. (10) were unable to
detect syntaxin binding with this domain using a blot overlay
assay, corroborating the findings reported here. It is tempting
to speculate that the acquisition of the C-terminal SNARE
motif is due to a gene fusion event during evolution and that
SNARE binding of the N-terminal domain subsequently degen-
erated. However, we cannot exclude that the N-terminal do-
main of tomosyn (particularly the WD40 repeats) interacts
with other intracellular proteins, either as an independent
entity or as a regulator of the C-terminal SNARE motif. In the
latter case, the SNARE motif would be constitutively “on” in
the intact molecule, because the presence of the N-terminal
domain did not have any measurable effect on the SNARE-
activity of the C-terminal domain.
Our data show that the SNARE motif of tomosyn does indeed
function as an R-SNARE in SNARE assembly and disassembly
reactions. The complex formed with syntaxin and SNAP-25 is
remarkably similar to the ternary SNARE complex formed
with synaptobrevin, strongly suggesting that it is represented
by a four-helix bundle characteristic for all SNAREs. The sim-
ilarities include 1:1:1:1 stoichiometry of the participating
SNARE motifs, unusual heat resistance, strong hysteresis dur-
ing folding-unfolding transitions, and major conformational
changes during assembly that proceeds from unstructured
monomers to a highly helical complex (Ref. 3, see Ref. 5 for
review). Furthermore, the recombinant SNARE motif of tomo-
syn binds to membrane-bound syntaxin 1 and SNAP-25 in a
manner indistinguishable from the cytoplasmic part of synap-
tobrevin. Synaptobrevin was previously shown to form cis-core
complexes under these conditions (24).
FIG. 5. The C-terminal region of tomosyn (residues 1051–1116)
inhibits Ca2-dependent exocytosis in a semi-intact system de-
rived from PC12 cells. PC12 cells were transfected with NPY-EGFP
as a granule content marker, followed by cell disruption, leading to the
generation of inverted lawns of plasma membranes (see A for visual-
ization of phospholipid membranes with TMA-DPH) containing bound
secretory granules (B and C). For the triggering and monitoring of
exocytosis, ATP, cytosol, and 500 nM free calcium were added, and
membrane sheets were imaged every minute for 30 min (see B and C for
the first and last image of a sequence). Exocytic activity of individual
granules resulted in abrupt changes in fluorescence intensity in the
sequence leading either to dimming (due to loss of GFP, compare
dashed circles in B and C) or brightening (due to pH-dequenching of
GFP, compare dotted circles in B and C) of individual granules (25). The
percentage of active granules (D) was related to all GFP-labeled gran-
ules present at the beginning (for details see Ref. 25). For each condi-
tion, the background exocytic activity in the absence of calcium was
measured separately and subtracted. For each experiment 6–14
(mean  10) membrane sheets were analyzed. Values are presented as
means  S.E. The concentration of synaptobrevin and tomosyn frag-
ments was 80 M.
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The fact that tomosyn functions as a SNARE in the forma-
tion of SNARE core complexes is not easily reconcilable with
the idea that the tomosyn-SNARE complex is an intermediate
in an activation sequence during which it removes Munc18
from syntaxin and “hands” it over to its cognate SNARE part-
ner synaptobrevin (see e.g. Ref. 10). Rather, tomosyn-contain-
ing SNARE complexes require the chaperone ATPase NSF for
disassembly that acts upon all partially and fully assembled
SNARE complexes. Insofar, tomosyn acts as a competitive in-
hibitor of synaptobrevin by occupying its binding site. Thus it is
possible that tomosyn fine-tunes the availability of the plasma
membrane SNAREs SNAP-25 and syntaxin for entering fusion-
competent trans-complexes. Such a scenario is in agreement
with the fact that an increase of intracellular tomosyn concen-
trations down-regulates exocytosis.
We have recently established that the plasma membrane
pools of syntaxin and SNAP-25 are essentially uncomplexed
and active under steady-state conditions (24). This indicates
that NSF maintains all SNAREs in a predominantly disassem-
bled state. Thus, the membrane pool of tomosyn is probably
relatively small, although we cannot exclude that disassembly
of tomosyn-SNARE complexes is slower than that of genuine
SNARE complexes, or down-regulated by its N-terminal do-
main. It is conceivable that tomosyn becomes locked at the
membrane as soon as NSF activity is reduced, which may
result in an overestimate of the membrane-bound pool in some
of our experiments. That overexpression of tomosyn reduces
the rate of evoked exocytosis does not necessarily imply that a
reduction of tomosyn would lead to an increase in exocytosis. In
any case we can exclude that tomosyn affects the exocytotic
fusion event itself, because no changes were observed in the
kinetics of single vesicle exocytosis.
It remains to be established to what extent the function of
tomosyn is confined to regulated exocytosis. Three splicing
variants of tomosyn, all containing the R-SNARE motif, were
described, one of which is ubiquitously expressed (10). The
SNARE motif of tomosyn was identified in yeast two-hybrid
screens searching for binding partners of syntaxin 4 and
SNAP-23, although binding to syntaxin 4 was not observed in
pull-down assays. Both syntaxin 4 and SNAP-23 are thought to
be involved in fusion events at the plasma membrane suggest-
TABLE I
Properties of individual amperometric signals in control cells and
cells overexpressing tomosyn full-length protein
Amperometric events were characterized with respect to charge (fC)
reflecting the area under spike, maximum amplitude (pA), 50–90% rise
time, and halfwidth (representing the duration of the spike at the 50%
value of its maximum amplitude). Only events with an amplitude larger
than 3 pA were included. Foot signals were analyzed with respect to
charge (fC), current amplitude (pA) and duration (microseconds). The
start of a foot signal was defined as the time point when the current
amplitude exceeds two times the average baseline noise standard devi-
ation; its end is indicated by the inflection point in the current signal
marking the transition between the slow and the fast increase of the
current amplitude during the foot and spike phase, respectively. Values
are given as mean  S.E.
(3.0 pA) Control (9 cells, 859events)
Tomosyn (12 cells, 212
events)
Event parameters
Charge (fC)a 34.9  1.2 27.5  1.8
Amplitude [pA] 11.9  1.2 9.7  0.8
50–90% rise time 668  34 576  63
Halfwidth (s) 2723  89 2400  147
Foot parameters n  153 n  50
Charge (fC) 6.1  0.6 6.1  0.9
Amplitude (pA) 4.4  0.2 3.8  0.4
Duration (s) 2562  204 2936  401
a fC, femtoCoulomb.
FIG. 6. Overexpression of tomosyn profoundly inhibits exocytosis from PC12 cells. A, representative amperometric recordings from
control cells (expressing EGFP) and cells overexpressing tomosyn full-length protein. Bar, stimulation of exocytosis with high K-containing
Ringer’s solution. B, average exocytotic activity of control (n  9) and tomosyn-transfected cells (n  12). Note the lack of an initial phase with
higher exocytotic activity in tomosyn-expressing cells (compare with A). Bar, stimulation with K-containing Ringer’s solution. Only amperometric
events with peak amplitudes 3 pA were included. C, overexpression of tomosyn leads to a strong reduction in the number of spikes evoked during
stimulation (control, 69  25 events; tomosyn-transfected, 14  6 events).
Tomosyn-SNARE Complexes in Exocytosis 31165
 at M














ing that tomosyns may be specific regulators of exocytosis in
many different cell types.
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